Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Stage Small Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03771404
What this trial is testing

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04624204
What this trial is testing

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 672
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Testing effectiveness (Phase 2)Study completedNCT01166191
What this trial is testing

Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)

Who this might be right for
Stage I-III Small Cell Lung Cancer
Maastricht Radiation Oncology 60
Not applicableStudy completedNCT04732520
What this trial is testing

Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Galvanize Therapeutics, Inc. 47
Not applicableStudy completedNCT01985113
What this trial is testing

Correlation Research of Thioredoxin Reductase in Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBenign Neoplasm of Lung
Hunan Province Tumor Hospital 165
Testing effectiveness (Phase 2)Study completedNCT00750269
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 120
Large-scale testing (Phase 3)Active Not RecruitingNCT03703297
What this trial is testing

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 730
Early research (Phase 1)Ended earlyNCT01918761
What this trial is testing

Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Central European Cooperative Oncology Group 5
Large-scale testing (Phase 3)Looking for participantsNCT07473128
What this trial is testing

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Pharmacosmos A/S 120
Not applicableLooking for participantsNCT04654364
What this trial is testing

Lung Cancer Registry

Who this might be right for
Lung CancerNSCLC Stage IVNSCLC, Stage III+2 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 500
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Large-scale testing (Phase 3)Not Yet RecruitingNCT05496166
What this trial is testing

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 348
Not applicableUnknownNCT03414944
What this trial is testing

Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases

Who this might be right for
Brain Metastases
Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT04638582
What this trial is testing

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
McGill University Health Centre/Research Institute of the McGill University Health Centre 6
Not applicableWithdrawnNCT01398124
What this trial is testing

Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Milton S. Hershey Medical Center
Not applicableStudy completedNCT02488850
What this trial is testing

Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Erasmus Medical Center 32
Large-scale testing (Phase 3)Study completedNCT00373425
What this trial is testing

Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors

Who this might be right for
Non-small Cell Lung Cancer
OSI Pharmaceuticals 1,252
Testing effectiveness (Phase 2)Ended earlyNCT00084487
What this trial is testing

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 21
Not applicableLooking for participantsNCT06743581
What this trial is testing

Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy
Centre hospitalier de l'Université de Montréal (CHUM) 24
Next Page